![Goro Takeda](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Goro Takeda
Gründer bei
Newton Biocapital Partners /Japan/
Profil
Goro Takeda is the founder of Shogoo Pharmaceuticals KK, founded in 2005, and Newton Biocapital Partners, founded in 2017, where he holds the title of Managing Partner.
He is currently a Managing Partner at FinTech Global Capital LLC.
Mr. Takeda's former positions include being a Venture Partner at Sofinnova Investments, Inc., and Deputy General Manager at Daiwa SMBC Capital Co., Ltd. He received an MBA from Northwestern University in 2001 and an undergraduate degree from Waseda University in 1990.
Aktive Positionen von Goro Takeda
| Unternehmen | Position | Beginn |
|---|---|---|
FinTech Global Capital LLC
 FinTech Global Capital LLC Investment ManagersFinance FGC is an active manager which invests in growth companies in a range of sectors including information and communication technology, new materials and life sciences. Their investment focus includes Japan, the US and Europe. Through their fund, the firm seeks to invest in Japanese companies aiming to expand business globally as well as in overseas companies aiming to establish a stronger presence in Japan by combining excellent technologies. FGC works to achieve these goals by maximizing their financial know-how and networks with those of the Development Bank of Japan and the global networks of top-tier US and European venture capital providers. | Private Equity Investor | 01.10.2009 |
Newton Biocapital Partners /Japan/ | Gründer | 04.04.2017 |
Ehemalige bekannte Positionen von Goro Takeda
| Unternehmen | Position | Ende |
|---|---|---|
Daiwa SMBC Capital Co., Ltd.
 Daiwa SMBC Capital Co., Ltd. Investment ManagersFinance Engages in private equity investments | Corporate Officer/Principal | 30.06.2006 |
Shogoo Pharmaceuticals KK
 Shogoo Pharmaceuticals KK Pharmaceuticals: MajorHealth Technology Provides novel pharmaceutical products | Gründer | - |
Daiwa SMBC Capital Co., Ltd.
Daiwa SMBC Capital Co., Ltd. Investment ManagersFinance Engages in private equity investments | Corporate Officer/Principal | - |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Private Equity Investor | - |
Ausbildung von Goro Takeda
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
96
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Finance |
Daiwa SMBC Capital Co., Ltd.
Daiwa SMBC Capital Co., Ltd. Investment ManagersFinance Engages in private equity investments | Finance |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Waseda University
 Waseda University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shogoo Pharmaceuticals KK
Shogoo Pharmaceuticals KK Pharmaceuticals: MajorHealth Technology Provides novel pharmaceutical products | Health Technology |
FinTech Global Capital LLC
FinTech Global Capital LLC Investment ManagersFinance FGC is an active manager which invests in growth companies in a range of sectors including information and communication technology, new materials and life sciences. Their investment focus includes Japan, the US and Europe. Through their fund, the firm seeks to invest in Japanese companies aiming to expand business globally as well as in overseas companies aiming to establish a stronger presence in Japan by combining excellent technologies. FGC works to achieve these goals by maximizing their financial know-how and networks with those of the Development Bank of Japan and the global networks of top-tier US and European venture capital providers. | Finance |
Newton Biocapital Partners /Japan/ |
